Lack of response to HBHA in HIV‐infected patients with latent tuberculosis infection

G. Delogu , V. Vanini , G. Cuzzi , T. Chiacchio
Scandinavian Journal of Immunology 84 ( 6) 344 -352

16
2016
Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis

E. Petruccioli , V. Vanini , T. Chiacchio , G. Cuzzi
Tuberculosis 106 ( 4) 38 -43

53
2017
Characterization of regulatory T cells identified as CD4+CD25highCD39+ in patients with active tuberculosis

T. Chiacchio , R. Casetti , O. Butera , V. Vanini
Clinical and Experimental Immunology 156 ( 3) 463 -470

65
2009
IP-10 is an additional marker to evaluate the RD1-specific responses in HIV-infected subjects

Elisa Petruccioli , Delia Goletti , Nicoletta Orchi , Teresa Chiacchio
European Respiratory Journal 38 4386

2011
Functional and memory status of M. tuberculosis specific T-cells in HIV-infected patients naïve to antiretroviral treatment

Elisa Petruccioli , Delia Goletti , Teresa Chiacchio , Carmela Pinnetti
European Respiratory Journal 44 3251

2014
Methylated HBHA produced in M. smegmatis discriminates between active and non-active TB disease among the QFT-IT-responders

Alessandra Bua , Stefania Zanetti , Giovanni Delogu , Valentina Vanini
European Respiratory Journal 38 1901

1
2011
Response to Mtb Rv2628 latency antigen associates with bacterial containment

Elisa Petruccioli , Kees L. M. C. Franken , Delia Goletti , Teresa Chiacchio
European Respiratory Journal 40 1876

2012
Effect of therapy on Quantiferon-Plus response in patients with active and latent tuberculosis infection.

Elisa Petruccioli , Teresa Chiacchio , Valentina Vanini , Gilda Cuzzi
Scientific Reports 8 ( 1) 15626

12
2018
Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.

Teresa Chiacchio , Giovanni Delogu , Valentina Vanini , Gilda Cuzzi
PLOS ONE 12 ( 8) 1 -18

24
2017
Impaired IFN-α-mediated Signal in Dendritic Cells Differentiates Active From Latent Tuberculosis

Stefania Parlato , Teresa Chiacchio , Debora Salerno , Linda Petrone
PLOS ONE 13 ( 1)

8
2018
New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response

Ornella Butera , Teresa Chiacchio , Stefania Carrara , Rita Casetti
BMC Infectious Diseases 9 ( 1) 182 -182

50
2009
Methylated HBHA Produced in M. smegmatis Discriminates between Active and Non-Active Tuberculosis Disease among RD1-Responders

Giovanni Delogu , Teresa Chiacchio , Valentina Vanini , Ornella Butera
PLoS ONE 6 ( 3) e18315

54
2011
IP-10 detection in urine is associated with lung diseases

Angela Cannas , Ludovica Calvo , Teresa Chiacchio , Gilda Cuzzi
BMC Infectious Diseases 10 ( 1) 333 -333

51
2010
Impact of antiretroviral and tuberculosis therapies on CD4 + and CD8 + HIV/M. tuberculosis-specific T-cell in co-infected subjects

Teresa Chiacchio , Elisa Petruccioli , Valentina Vanini , Gilda Cuzzi
Immunology Letters 198 33 -43

13
2018
Modulation of interferon-gamma response to QuantiFERON-TB-plus detected by enzyme-linked immunosorbent assay in patients with active and latent tuberculosis infection

Elisa Petruccioli , Valentina Vanini , Teresa Chiacchio , Daniela M. Cirillo
International Journal of Mycobacteriology 5 S143 -S144

4
2016
Modulation of CD4 and CD8 response to QuantiFERON-TB Plus in patients with active tuberculosis and latent tuberculosis infection followed over time during treatment

Teresa Chiacchio , Elisa Petruccioli , Ilaria Pepponi , Valentina Vanini
International Journal of Mycobacteriology 5 S141 -S142

2
2016
Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kit

Elisa Petruccioli , Teresa Chiacchio , Ilaria Pepponi , Valentina Vanini
The International Journal of Mycobacteriology 5

3
2016
Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children.

Michela Sali , Danilo Buonsenso , Pamela D'Alfonso , Flavio De Maio
Journal of Infection 77 ( 6) 526 -533

12
2018
Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases.

Teresa Chiacchio , Elisa Petruccioli , Valentina Vanini , Gilda Cuzzi
Journal of Infection 79 ( 1) 15 -23

5
2019